Bahadorani S, Maclean K, Wannamaker K, et al. - In this IRB-approved retrospective review, researchers assessed the impacts of topical nonsteroidal anti-inflammatory drugs (NSAIDs) on the timing of central serous chorioretinopathy (CSCR), common retinopathy that is characterized by spontaneous serous detachment of the neurosensory retina in the macular region, recovery. This investigation was carried out on patients that had been diagnosed with a new-onset, symptomatic case of CSCR. There was no statistical significance during the initial presentation between central macular thickness (CMT) and visual acuity of treatment and control groups. However, CMT reductions were significantly higher in the treatment group at the follow-up visit than in the control group. Using topical NSAIDs in the treatment of acute CSCR results in a faster reduction rate in the volume of subretinal fluid over a follow-up period of a few weeks.